{"a":[{"_":"Alnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneer","$":{"href":"/biotech/alnylam-pays-inceptive-30m-transform-sirna-design-ai-pioneer","hreflang":"en"}}]}

Summary

Alnylam partnered with Inceptive Nucleics, paying $30 million to leverage AI-enabled drug design capabilities for siRNA development. The collaboration brings together Alnylam's siRNA expertise with Inceptive's artificial intelligence technology.